Loading…
Small hepatocellular carcinoma : Diagnostics according to guidelines and established in the clinical setting
The diagnosis of hepatocellular carcinoma (HCC)-especially the characterization of small lesions
Saved in:
| Published in: | Radiologe 2022-03, Vol.62 (3), p.239-246 |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | ger |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | |
| container_end_page | 246 |
| container_issue | 3 |
| container_start_page | 239 |
| container_title | Radiologe |
| container_volume | 62 |
| creator | Vogl, Thomas J Mader, Christoph Michalik, Sabine Hammerstingl, Renate Koch, Vitali |
| description | The diagnosis of hepatocellular carcinoma (HCC)-especially the characterization of small lesions |
| doi_str_mv | 10.1007/s00117-021-00965-6 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2620763117</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2620763117</sourcerecordid><originalsourceid>FETCH-LOGICAL-p141t-efc16832fdab55060466b8b26becf10ae48d82814456c81e8ecddcece580a5903</originalsourceid><addsrcrecordid>eNo1kDtPxDAQhC0kxB0Hf4ACuaQJrJ3EcejQ8ZROogDqaGNvckbOg9gp-PcEcVQrzX6z2hnGLgRcC4DiJgAIUSQgRQJQqjxRR2wtslQmUoBcsdMQPhdElrI8Yas0h7QoNayZf-vQe76nEeNgyPvZ48QNTsb1Q4f8lt87bPshRGcCR2OGybq-5XHg7ewsedfToveWU4hYexf2ZLnredwTN8vWGfQ8UIyL64wdN-gDnR_mhn08Prxvn5Pd69PL9m6XjCITMaHGCKVT2Vis8xwUZErVupaqJtMIQMq01VKLLMuV0YI0GWsNGco1YF5CumFXf3fHafial8eqzoXfcNjTMIdKKgmFSpfCFvTygM51R7YaJ9fh9F39N5T-AAtuaHw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2620763117</pqid></control><display><type>article</type><title>Small hepatocellular carcinoma : Diagnostics according to guidelines and established in the clinical setting</title><source>Alma/SFX Local Collection</source><creator>Vogl, Thomas J ; Mader, Christoph ; Michalik, Sabine ; Hammerstingl, Renate ; Koch, Vitali</creator><creatorcontrib>Vogl, Thomas J ; Mader, Christoph ; Michalik, Sabine ; Hammerstingl, Renate ; Koch, Vitali</creatorcontrib><description>The diagnosis of hepatocellular carcinoma (HCC)-especially the characterization of small lesions <2 cm-continues to be a radiological challenge.
In the current S3 guideline on diagnosis and therapy of HCC, contrast-enhanced imaging examinations, such as contrast-enhanced ultrasonography (CEUS), computed tomography (CT), and magnetic resonance imaging (MRI), are still the diagnostic standard.
HCC in the cirrhotic liver should be diagnosed by its typical contrast-enhanced pattern in the MRI. In addition, the use of quality assurance instruments such as LI-RADS (Liver Imaging Reporting and Data System) contributes to the desired consistency of findings, even with small ambiguous findings.
Many studies have shown that the LI-RADS classification reflects the likelihood of HCC and other malignant liver lesions.
Guidelines and quality assurance instruments contribute to a more precise diagnosis in patients with suspected HCC.
A guideline-compliant diagnostic algorithm and the LI-RADS should be used across the board for accurate HCC diagnostics.</description><identifier>EISSN: 1432-2102</identifier><identifier>DOI: 10.1007/s00117-021-00965-6</identifier><identifier>PMID: 35037980</identifier><language>ger</language><publisher>Germany</publisher><subject>Carcinoma, Hepatocellular - diagnostic imaging ; Contrast Media ; Humans ; Liver Neoplasms - diagnostic imaging ; Magnetic Resonance Imaging - methods ; Retrospective Studies ; Sensitivity and Specificity ; Ultrasonography - methods</subject><ispartof>Radiologe, 2022-03, Vol.62 (3), p.239-246</ispartof><rights>2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35037980$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vogl, Thomas J</creatorcontrib><creatorcontrib>Mader, Christoph</creatorcontrib><creatorcontrib>Michalik, Sabine</creatorcontrib><creatorcontrib>Hammerstingl, Renate</creatorcontrib><creatorcontrib>Koch, Vitali</creatorcontrib><title>Small hepatocellular carcinoma : Diagnostics according to guidelines and established in the clinical setting</title><title>Radiologe</title><addtitle>Radiologe</addtitle><description>The diagnosis of hepatocellular carcinoma (HCC)-especially the characterization of small lesions <2 cm-continues to be a radiological challenge.
In the current S3 guideline on diagnosis and therapy of HCC, contrast-enhanced imaging examinations, such as contrast-enhanced ultrasonography (CEUS), computed tomography (CT), and magnetic resonance imaging (MRI), are still the diagnostic standard.
HCC in the cirrhotic liver should be diagnosed by its typical contrast-enhanced pattern in the MRI. In addition, the use of quality assurance instruments such as LI-RADS (Liver Imaging Reporting and Data System) contributes to the desired consistency of findings, even with small ambiguous findings.
Many studies have shown that the LI-RADS classification reflects the likelihood of HCC and other malignant liver lesions.
Guidelines and quality assurance instruments contribute to a more precise diagnosis in patients with suspected HCC.
A guideline-compliant diagnostic algorithm and the LI-RADS should be used across the board for accurate HCC diagnostics.</description><subject>Carcinoma, Hepatocellular - diagnostic imaging</subject><subject>Contrast Media</subject><subject>Humans</subject><subject>Liver Neoplasms - diagnostic imaging</subject><subject>Magnetic Resonance Imaging - methods</subject><subject>Retrospective Studies</subject><subject>Sensitivity and Specificity</subject><subject>Ultrasonography - methods</subject><issn>1432-2102</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNo1kDtPxDAQhC0kxB0Hf4ACuaQJrJ3EcejQ8ZROogDqaGNvckbOg9gp-PcEcVQrzX6z2hnGLgRcC4DiJgAIUSQgRQJQqjxRR2wtslQmUoBcsdMQPhdElrI8Yas0h7QoNayZf-vQe76nEeNgyPvZ48QNTsb1Q4f8lt87bPshRGcCR2OGybq-5XHg7ewsedfToveWU4hYexf2ZLnredwTN8vWGfQ8UIyL64wdN-gDnR_mhn08Prxvn5Pd69PL9m6XjCITMaHGCKVT2Vis8xwUZErVupaqJtMIQMq01VKLLMuV0YI0GWsNGco1YF5CumFXf3fHafial8eqzoXfcNjTMIdKKgmFSpfCFvTygM51R7YaJ9fh9F39N5T-AAtuaHw</recordid><startdate>202203</startdate><enddate>202203</enddate><creator>Vogl, Thomas J</creator><creator>Mader, Christoph</creator><creator>Michalik, Sabine</creator><creator>Hammerstingl, Renate</creator><creator>Koch, Vitali</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>202203</creationdate><title>Small hepatocellular carcinoma : Diagnostics according to guidelines and established in the clinical setting</title><author>Vogl, Thomas J ; Mader, Christoph ; Michalik, Sabine ; Hammerstingl, Renate ; Koch, Vitali</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p141t-efc16832fdab55060466b8b26becf10ae48d82814456c81e8ecddcece580a5903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2022</creationdate><topic>Carcinoma, Hepatocellular - diagnostic imaging</topic><topic>Contrast Media</topic><topic>Humans</topic><topic>Liver Neoplasms - diagnostic imaging</topic><topic>Magnetic Resonance Imaging - methods</topic><topic>Retrospective Studies</topic><topic>Sensitivity and Specificity</topic><topic>Ultrasonography - methods</topic><toplevel>online_resources</toplevel><creatorcontrib>Vogl, Thomas J</creatorcontrib><creatorcontrib>Mader, Christoph</creatorcontrib><creatorcontrib>Michalik, Sabine</creatorcontrib><creatorcontrib>Hammerstingl, Renate</creatorcontrib><creatorcontrib>Koch, Vitali</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Radiologe</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vogl, Thomas J</au><au>Mader, Christoph</au><au>Michalik, Sabine</au><au>Hammerstingl, Renate</au><au>Koch, Vitali</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Small hepatocellular carcinoma : Diagnostics according to guidelines and established in the clinical setting</atitle><jtitle>Radiologe</jtitle><addtitle>Radiologe</addtitle><date>2022-03</date><risdate>2022</risdate><volume>62</volume><issue>3</issue><spage>239</spage><epage>246</epage><pages>239-246</pages><eissn>1432-2102</eissn><abstract>The diagnosis of hepatocellular carcinoma (HCC)-especially the characterization of small lesions <2 cm-continues to be a radiological challenge.
In the current S3 guideline on diagnosis and therapy of HCC, contrast-enhanced imaging examinations, such as contrast-enhanced ultrasonography (CEUS), computed tomography (CT), and magnetic resonance imaging (MRI), are still the diagnostic standard.
HCC in the cirrhotic liver should be diagnosed by its typical contrast-enhanced pattern in the MRI. In addition, the use of quality assurance instruments such as LI-RADS (Liver Imaging Reporting and Data System) contributes to the desired consistency of findings, even with small ambiguous findings.
Many studies have shown that the LI-RADS classification reflects the likelihood of HCC and other malignant liver lesions.
Guidelines and quality assurance instruments contribute to a more precise diagnosis in patients with suspected HCC.
A guideline-compliant diagnostic algorithm and the LI-RADS should be used across the board for accurate HCC diagnostics.</abstract><cop>Germany</cop><pmid>35037980</pmid><doi>10.1007/s00117-021-00965-6</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 1432-2102 |
| ispartof | Radiologe, 2022-03, Vol.62 (3), p.239-246 |
| issn | 1432-2102 |
| language | ger |
| recordid | cdi_proquest_miscellaneous_2620763117 |
| source | Alma/SFX Local Collection |
| subjects | Carcinoma, Hepatocellular - diagnostic imaging Contrast Media Humans Liver Neoplasms - diagnostic imaging Magnetic Resonance Imaging - methods Retrospective Studies Sensitivity and Specificity Ultrasonography - methods |
| title | Small hepatocellular carcinoma : Diagnostics according to guidelines and established in the clinical setting |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T17%3A50%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Small%20hepatocellular%20carcinoma%20:%20Diagnostics%20according%20to%20guidelines%20and%20established%20in%20the%20clinical%20setting&rft.jtitle=Radiologe&rft.au=Vogl,%20Thomas%20J&rft.date=2022-03&rft.volume=62&rft.issue=3&rft.spage=239&rft.epage=246&rft.pages=239-246&rft.eissn=1432-2102&rft_id=info:doi/10.1007/s00117-021-00965-6&rft_dat=%3Cproquest_pubme%3E2620763117%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p141t-efc16832fdab55060466b8b26becf10ae48d82814456c81e8ecddcece580a5903%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2620763117&rft_id=info:pmid/35037980&rfr_iscdi=true |